glutathione solubility in chloroform Nano-Structured Lipid Carrier-Based Oral Formulation Mediates Renoprotection against Cyclophosphamide-Induced Nephrotoxicity, and Improves Oral Bioavailability of Glutathione Confirmed through RP-HPLC Micellar Liquid Chromatography Pluripotent stem-cell-based screening uncovers category:healing-repair Cantidad:5 PIEZAS

glutathione solubility in chloroform Nano-Structured Lipid Carrier-Based Oral Formulation Mediates Renoprotection against Cyclophosphamide-Induced Nephrotoxicity, and Improves Oral Bioavailability of Glutathione Confirmed through RP-HPLC Micellar Liquid Chromatography Pluripotent stem-cell-based screening uncovers category:healing-repair Cantidad:5 PIEZAS

Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy: Cell

The majority of the mimics are powerful HGF antagonists with substantial anti-angiogenic and anti-cancer activity

category:healing-repair

Cantidad:5 PIEZAS

Abbreviations in the Examples are as follows: mM = millimolar uM = micromolar uL = micro liter GAP = glutamate and cystine and glycine mix GAP 5 = 4 uM sodium pyroglutamic acid, 5 uM cystine, 16 uM glycine GAP 10 = 8 uM sodium pyroglutamic acid, 10 uM cystine, 32 uM glycine GAP 20 = 16 uM sodium pyroglutamic acid, 20 uM cystine, 64 uM glycine NaPCA = sodium pyroglutamic acid (also known as sodium pyrrolidonecarboxylic acid) HR=4-hexylresorcinol BR=4-butylresorcinol IPR = 4-isopropylresorcinol ER = 4-ethylresorcinol PER = 4- (1-phenylethyl) resorcinol MR = 4-methylresorcinol 4-CHMR = 4- (cyclohexylmethyl) resorcinol DEC = Diethyl L-cystinate dihydrochloride CDME = L-Cystine dimethyl ester dihydrochloride DTBC = Ditert-butyl L-cystinate dihydrochloride Example 1 Example 1 evaluated various combinations of 4-alkyl resorcinols and amino acids constituting GSH building blocks for potentiating intracellular GSH production